Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Single-arm, Multi-center Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy

NCT03778853 is registered in ClinicalTrials.gov with LanZhou University as lead sponsor.

NCT NCT03778853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03778853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Single-arm, Multi-center Study of Anlotinib in Advanced Non-squamous NSCLC Patients in the Elderly Without Systemic Chemotherapy
Lead sponsor
LanZhou University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2019
Completion date
December 31, 2019
Enrollment
72 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced non-squamous nsclc